Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: J Immunol. 2011 Aug 1;187(5):2569–2577. doi: 10.4049/jimmunol.1100374

Figure 3.

Figure 3

Secondary expansion and cytokine production for peptide-stimulated CD8+ T cells primed initially in Treg-ablated or Treg-sufficient mice. A. Percent and number of CD90.1+ CD8+ cells among splenocytes prior to (D30), or days 3 (D30 + 3) and 5 (D30 + 5) after Lm-OVA infection in mice treated with peptide 30 days prior. B. Representative FACS plots demonstrating percent IFN-γ, IL-2, and TNF-α producing CD90.1+ CD8+ T cells day 5 after secondary Lm-OVA infection (D30 + 5 after peptide stimulation) directly ex-vivo (no stim) or after peptide stimulation. These data are representative of three experiments containing 8–12 mice per group. Bar, one standard error.